Dynex® Total Ab ELISA for COVID-19 | Fast Antibody Screening

Total Ab ELISA for SARS-CoV-2 Virus (COVID-19)

Serological and Virological Markers of COVID-19

Wantai SARS-CoV-2 Ab ELISA is a highly sensitive and specific diagnostic kit intended for high-throughput, fast antibody screening for patients suspected for COVID-19 infection.

Interested in learning more about Wantai SARS-CoV-2 Ab ELISA?

COVID-19 serological markers dynamics (Total Ab/IgM/IgG):

20%-40% of the patients developed antibodies on days 0-7 after onset
60%-70% of the patients developed antibodies on days 8-11 after onset
> 90% of the patients had detectable levels of antibodies starting from day 12 after onset

COVID-19 molecular marker dynamics (RNA):

RNA was detected in 60-75% of the patients on days 0-8 after onset
60%-70% of the patients developed antibodies on days 8-11 after onset
>RNA levels decrease to 40-50% starting from day 9 after onset

For prescription use only.
For in vitro diagnostic use only.
For use under Food and Drug Administration’s Emergency Use Authorization (EUA) only.